Insulin-like growth factor I (IGF-I) serum level modifications during transdermal estradiol treatment in postmenopausal women: A possible bimodal effect depending on basal IGF-I values
- 1 January 1998
- journal article
- research article
- Published by Taylor & Francis in Gynecological Endocrinology
- Vol. 12 (4) , 259-266
- https://doi.org/10.3109/09513599809015598
Abstract
The objective of this study was to determine the influence of transdermal estradiol administration on insulin-like growth factor I (IGF-I) serum level in a series larger than those published to date. Thirty-nine postmenopausal women with vasomotor symptoms were studied; blood samples (after overnight fast) were obtained just before and at the 6th month of treatment with transdermal estradiol 0.05 mg/day, and serum levels of IGF-I, growth hormone and sex hormone binding globulin (SHBG) were evaluated. Sixteen of the 39 women did not show variations of IGF-I values (group A), while 11 showed an increase (group B) and 12 showed a decrease (group C) by at least 20% with transdermal estradiol treatment. IGF-I basal levels were higher in group C as compared to group A (p < 0.05) and to group B (p < 0.01), intermediate in group A, and lower in group B. Group C showed a significant increase of SHBG values with transdermal estradiol treatment. Transdermal estradiol seems to induce a bimodal effect on IGF-I serum levels, depending on IGF-I basal values. This could be caused by a different responsivity to estrogen action on the liver (the major site of circidating IGF-I production) and also, possibly, by a different degree in insulin sensitivity changes caused by estrogen.Keywords
This publication has 23 references indexed in Scilit:
- Serum IGF-1 and Binding Proteins 1 and 3 in Postmenopausal Women and the Effects of EstrogenMenopause, 1996
- Effects of hormone replacement therapy on growth hormone secretion patterns in correlation to somatometric parameters in healthy postmenopausal womenMaturitas, 1995
- Insulin-like growth factors I and II in healthy women with and without established osteoporosisActa Endocrinologica, 1995
- Role of insulin-like growth factors in steroid modulated proliferationThe Journal of Steroid Biochemistry and Molecular Biology, 1994
- The Insulin-Like Growth Factor I Generation Test: Resistance to Growth Hormone With Aging and Estrogen Replacement TherapyHormone and Metabolic Research, 1994
- Lack of Effect of Transdermal Estrogen on the Growth Hormone-Insulin-Like Growth Factor AxisHormone and Metabolic Research, 1994
- Hormonal treatments modulate pulsatile plasma growth hormone, gonadotrophin and osteocalcin levels in postmenopausal womenMaturitas, 1993
- Transdermal 17β-estradiol combined with oral progestogen increases plasma levels of insulin-like growth factor-l in postmenopausal womenJournal of Endocrinological Investigation, 1992
- Contrasting Effects of Oral and Transdermal Routes of Estrogen Replacement Therapy on 24-Hour Growth Hormone (GH) Secretion, Insulin-Like Growth Factor I, and GH-Binding Protein in Postmenopausal Women*Journal of Clinical Endocrinology & Metabolism, 1991
- Effects of Progestin-Opposed Transdermal Estrogen Administration on Growth Hormone and Insulin-Like Growth Factor-I in Postmenopausal Women of Different Ages*Journal of Clinical Endocrinology & Metabolism, 1991